학술논문

Safety and efficacy of sofosbuvir–velpatasvir–voxilaprevir for re-treatment of chronic hepatitis C virus infection in patients with previous direct-acting antiviral treatment failure in Rwanda (SHARED-3): a single-arm trial
Document Type
Article
Source
In The Lancet Gastroenterology & Hepatology June 2022 7(6):542-551
Subject
Primary Research
Articles
Language
ISSN
2468-1253